Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent, Clariscan (gadoterate meglumine), in pre-filled syringes. #RSNA20
News | Contrast Media
GE Healthcare Announces U.S. FDA approval of macrocyclic MRI Contrast Agent Clariscan in Pre-Filled Syringes

November 26, 2020 — GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent ...

Time November 26, 2020
arrow
Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging solutions in an immersive digital experience at the first all-virtual Radiological Society of North America (RSNA) annual meeting being held November 29 through December 5.
News | Contrast Media Injectors
Bracco Showcases Immersive Digital Experience at RSNA20

November 17, 2020 — Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging ...

Time November 17, 2020
arrow
Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the 2020 annual meeting of the Radiological Society of North America (RSNA).
News | Contrast Media
Guerbet to Showcase its UNIK Solution at RSNA 2020

November 17, 2020 — Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the ...

Time November 17, 2020
arrow
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 
Feature | Magnetic Resonance Imaging (MRI)
Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events

October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very ...

Time October 29, 2020
arrow
When new installations are ordered, the DAS team at Bracco matches a specialist with the installation based on specialty, learning style and industry awareness. This approach was helpful at Beaufort Memorial Hospital in Beaufort, S.C., which just recently transitioned to the Bracco EmpowerCTA+ Injector System.
Sponsored Content | Blog | Contrast Media
BLOG: Training and Vendor Support Key to Successful Device Upgrade

Transitioning to a new device vendor can provide improvements to outdated technology and workflow. It also requires a ...

Time October 20, 2020
arrow
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025
News | Contrast Media Injectors
Contrast Media Injectors Market Projected at $1.9 billion by 2025

September 2, 2020 — According to the new market research report "Contrast Media Injectors Market By Product (Injector ...

Time September 02, 2020
arrow
The radiology department uses Bracco’s Empower CTA injector system and has a been a Bracco customer for more than 15 years.
Sponsored Content | Blog | Contrast Media Injectors
BLOG: Reliability and Customer Service Key to Injector Uptime and CT Department Workflow

In a busy hospital imaging department, maintaining high device uptime levels is critical. If an injector malfunctions or ...

Time August 20, 2020
arrow
Subtle's AI improves MRI safety exams by reducing gadolinium dose
News | Artificial Intelligence
Subtle Medical Awarded Phase II Funding of $1.6 Million SBIR Grant for Safer MRI Exams

August 17, 2020 — Subtle Medical is approved for Phase II of its NIH SBIR grant to develop an innovative artificial ...

Time August 17, 2020
arrow
The first and only FDA-approved gadolinium-based contrast agent for multi-patient dosing with an FDA-cleared Transfer Spike in the MR suite
News | Contrast Media
FDA Approves Gadavist (gadobutrol) Imaging Bulk Package

August 14, 2020 — The U.S. Food and Drug Administration (FDA) announced the approval of the Gadavist (gadobutrol) ...

Time August 14, 2020
arrow
The global contrast media market is projected to grow at a CAGR of 4.23% to reach US$7,113.91 million by 2025 from US$5,548.19 million in 2019, according to a new report from ResearchandMarkets.com
News | Contrast Media
Global Contrast Media Market Report 2020-2025: $7.1 Billion Industry Assessment

July 22, 2020 — The global contrast media market is projected to grow at a CAGR of 4.23% to reach US$7,113.91 million by ...

Time July 22, 2020
arrow
Guerbet shows its commitment to healthcare professionals with two ranges of consumables selected for their injection solutions
News | Contrast Media Injectors
Guerbet Segments Consumables in Two Essential and Excellence Ranges

June 29, 2020 — Guerbet has launched a new "consumables.guerbet.com" website presenting its Essential and Excellence ...

Time June 29, 2020
arrow
The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio
News | Contrast Media Injectors
Contrast Injectors Market Growth and Trends

June 17, 2020 — Technavio has been monitoring the contrast injectors market and it is poised to grow by $613.47M during ...

Time June 17, 2020
arrow
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease
News | Contrast Media
FDA Approves TAUVID for Use in Patients Being Evaluated for Alzheimer’s Disease

June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography ...

Time June 01, 2020
arrow
Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp
News | Magnetic Resonance Imaging (MRI)
MRI's Environmental Impact

May 26, 2020 — Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river ...

Time May 26, 2020
arrow
Sponsored Content | Videos | Contrast Media Injectors
itnTV “Conversations”: Radiology Trends with Bayer’s Dennis Durmis

At this year’s RSNA ITN sat down with Dennis Durmis, Senior Vice President, Bayer Radiology to discuss Radiology trends ...

Time May 22, 2020
arrow
Gadolinium-based contrast agents
News | Contrast Media
Researchers Brighten Path for Creating New Type of MRI Contrast Agent

February 6, 2020 — University of Texas at Dallas researchers are breathing new life into an old MRI contrast agent by ...

Time February 06, 2020
arrow
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma
Feature | Contrast Media Injectors | By Matthew Kuhn, M.D., FACR
Artificial Intelligence Processes Provide Solutions to Gadolinium Retention Concerns

Gadolinium-based contrast agents (GBCAs) are widely used in medical imaging to provide essential diagnostic information ...

Time January 30, 2020
arrow
Feature | Contrast Media Injectors | By Melinda Taschetta-Millane
Contrast Media Injectors Market Outlook

Contrast media injector technology has seen several recent advances, such as cutting costs by reducing contrast waste ...

Time January 30, 2020
arrow
Gadolinium based contrast dye in brain MRI
News | Contrast Media
Voluntary Dismissal of Chuck Norris Gadolinium Case Involving Bracco

January 17, 2020 — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world’s leading ...

Time January 17, 2020
arrow
Results were presented at RSNA19 for the comparison of ProHance (Gadoteridol) Injection, 279.3 mg/mL and Gadavist (gadobutrol) Injection in MRI of the brain (the TRUTH study)
News | Contrast Media
AI Software Confirms the Results of a Large Scale Comparison of Gadoteridol and Gadavist Injection

December 10, 2019 — Bracco Diagnostics Inc., the U.S subsidiary of Bracco Imaging S.p.A., a leading global company in ...

Time December 10, 2019
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now